genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
FDA Rebuffs Vanda Application for Hetlioz in Jet Lag Disorder
Tech Exclusives
Ovarian Cancer Drug Resistance Protein Identified
Genetics
Neutrophils Shown to Play the Key Role in Gallstone Formation
Neuroscience
CRISPR Interference Screens Probe Gene Function in Human Neurons
News
Antibiotic Resistance Thwarted with Biosurfactant
Insights
Artificial Intelligence
Let There Be Sound: Turning Amino Acids into Tunes to Better…
Neuroscience
The Worm Gets a Wiring Diagram
On Your Radar
Set Phages to Kill
Insights
DNA Sequencing Accuracy Comes a Long Way
Insights
Top 10 Companies Leveraging Gene Editing in 2019
A-Lists
Insights
Top 10 Companies Leveraging Gene Editing in 2019
Insights
Top 10 Young Companies in the Money, January–July 2019
August 2019 Vol. 39 No. 8
Top 10 Biopharma IPOs of January–June 2019
Insights
Top 10 M&A Deals of January–June 2019
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Tech Exclusives
Ovarian Cancer Drug Resistance Protein Identified
Neuroscience
The Worm Gets a Wiring Diagram
News
Antibiotic Resistance Thwarted with Biosurfactant
News
Drug Speeds Renewal of Blood Depleted by Chemo, Radiation
Magazine
All
Supplement
Tech Exclusives
Medical Cannabis Poses Unique Testing Challenges
Tech Exclusives
Single-Use Technology Has Biopharma Sizing Up the Recycling Bin
Microfluidics
Microfluidics Stands on the Shoulders of Microfab Giants
On Your Radar
A Finger on the Pulse of Genome Editing
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Improving Large Molecule Production Processes by Integrating Innovative Technology Solutions
August 2019 Vol. 39 No. 8
Cloud-Based Water Monitoring
Tech Exclusives
Oncology’s Fifth Pillar: Cellular Immunotherapy
August 2019 Vol. 39 No. 8
Accelerating Forward Engineering at Genome Scale
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Therapeutics
Autoimmune Disease Drugs
Autoimmune Disease Drugs
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Autoimmune Disease Drugs
Multiple Sclerosis Suppressed in Mouse Model by Oft-Overlooked Immune System Cell Type
Autoimmune Disease Drugs
Merck & Co. Expands Pipeline in Cancer, Fibrosis, Autoimmune Diseases by Acquiring Tilos for Up to $773M
Autoimmune Disease Drugs
Genentech, Parvus Therapeutics Launch Up-to-$800M Autoimmune Collaboration
Autoimmune Disease Drugs
Cellular Stress, Not Infection, May Rouse Slumbering MS-Linked Retroviruses
Autoimmune Disease Drugs
Lilly, Avidity to Partner on Immunology Drugs in Up-to-$440M Collaboration
Autoimmune Disease Drugs
Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration
Autoimmune Disease Drugs
Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand
Autoimmune Disease Drugs
argenx Plans Autoimmune Treatments Using Halozyme’s ENHANZE Drug-Delivery Technology
Autoimmune Disease Drugs
Top 10 GEN News Articles of 2018
Autoimmune Disease Drugs
Lilly, Aduro to Develop STING Pathway Inhibitors for Autoimmune Diseases
Autoimmune Disease Drugs
Microbiome Modeling Reveals How Bacteria Shape Host Fitness
Autoimmune Disease Drugs
New Work Opens Door to Manipulating Aberrant Calcium Signaling in Immune...
Autoimmune Disease Drugs
GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development
Autoimmune Disease Drugs
Merck & Co. Partners with Sutro on Cytokine Derivatives for Cancer,...
Autoimmune Disease Drugs
Pollution and Genes Work Together to Increase Severity of Rheumatoid Arthritis
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![GlaxoSmithKline (GSK) has made a $300 million equity investment in 23andMe under a collaboration designed to accelerate development of new therapies for both companies by using genetic data to identify new drug targets. [Source: © fotoliaxrender/Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug5_2014_56448122_DNAblue_NovelDiagnosticGenomic12114111424-324x160.jpg "GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development")
![Individuals with a particular version of a gene have an increased risk for rheumatoid arthritis and the severity of bone damage. [National Library of Medicine]](https://www.genengnews.com/wp-content/uploads/2018/08/Apr19_2018_NLM_RheumatoidArthritis2477013519-324x160.jpg "Pollution and Genes Work Together to Increase Severity of Rheumatoid Arthritis")
